FDA

Beltway Confidential

Let the babies have their milk and drink it too

Washington Examiner · June 5, 2023 6:16 am

Insulin can cost an uninsured patient between $120 to $400 per month. By comparison, some generics would only cost about $4. (AP Photo)

Berberine: Experts warn ‘nature’s Ozempic’ not worth its weight

Gabrielle M. Etzel · June 4, 2023 10:00 am

Beltway Confidential

FDA’s distorted priorities are costly

Henry Miller · June 2, 2023 6:02 am

A lab technician working a bottle containing for COVID-19 vaccine testing at Chula Vaccine Research Center, run by Chulalongkorn University in Bangkok, Thailand, Monday, May 25, 2020. Thai health officials said that scientists in Thailand have had promising results in testing a COVID-19 vaccine candidate on mice, and have begun testing on monkeys.

COVID-19 vaccines: The latest on recommendations and public attitudes

Gabrielle M. Etzel · May 31, 2023 9:00 am

Neuralink approved by FDA for brain implant trial on humans

Gabrielle M. Etzel · May 25, 2023 11:33 pm

Ex-FDA commissioner pins drug shortage on Inflation Reduction Act

Jenny Goldsberry · May 22, 2023 12:40 am

Boxes of the drug mifepristone line a shelf at the West Alabama Women's Center in Tuscaloosa, Ala., on Wednesday, March 16, 2022.

Republicans advance spending bill that would reverse FDA rule allowing mail-order abortion pill

Cami Mondeaux · May 19, 2023 3:18 pm

FDA advisory panel recommends over-the-counter birth control pills

Brady Knox · May 10, 2023 7:12 pm

Packages of Mifepristone tablets are displayed at a family planning clinic on April 13, 2023, in Rockville, Maryland. A Massachusetts appeals court temporarily blocked a Texas-based federal judgeâs ruling that suspended the FDAâs approval of the abortion drug Mifepristone, which is part of a two-drug regimen to induce an abortion in the first trimester of pregnancy in combination with the drug Misoprostol.

Why Big Pharma sees the abortion drug legal fight as a grave business risk

Kaelan Deese · May 4, 2023 11:00 am

US FDA Approves GSKâs AREXVY, the Worldâs First Respiratory Syncytial Virus (RSV) Vaccine for Older Adults. (Business Wire)

FDA approves first RSV vaccine for adults 60 and older

Brady Knox · May 3, 2023 8:38 pm

President Trump signed into law the FDA Reauthorization Act of 2017 on Friday. It reauthorizes a program in which drug and device makers pay the FDA a fee for every new product application, and the agency uses that money to hire more people and speed up approvals. (AP Photo/Andrew Harnik, File)

Beltway Confidential

FDA’s ‘accelerated approval’ pathway for drugs is important but imperfect

Henry Miller · May 3, 2023 10:04 am

A man breathes vape from an e-cigarette at a vape shop in London, Friday, Aug. 17, 2018.

Watchdog group says FDA not following its own research on vaping

Washington Examiner · April 30, 2023 12:37 pm